Meta-analysis: VR exposure works as well as evidence-based alternatives, with a dose-response pattern
How this was rated
Quantitative meta-analysis using standard methods, pooling effect sizes across multiple primary studies. Confidence is bounded by the quality and homogeneity of the included primary studies, several of which had small samples and inconsistent comparators.
Ratings use a simplified four-tier scheme (High, Moderate, Low, Very Low) informed by the GRADE working group. Learn more about how studies are rated.
A quantitative meta-analysis of VR exposure for anxiety disorders found that VR-based treatment produced large gains over waitlist, equivalent gains to established evidence-based alternatives, and a clear dose-response relationship - more sessions produced more benefit.
A well-conducted meta-analysis providing pooled evidence that VR exposure is comparably effective to established alternatives for anxiety disorders, with a documented dose-response pattern; primary studies remain modest in number and size.
Key findings
- VR exposure produced large effect sizes versus waitlist controls; 23 studies pooled, total n=608
- VR exposure produced effects equivalent to non-VR evidence-based interventions
- A dose-response relationship was documented - more sessions produced larger gains
- Real-life impact and stability of gains were comparable to non-VR alternatives
- Dropout rates in VR exposure were equivalent to those in in-vivo exposure
Background
By 2012, virtual reality exposure therapy had been studied in several anxiety conditions, with primary trials accumulating across specific phobias, social anxiety, and PTSD. Individual trials had reported encouraging results, but each was limited by sample size and study design. A quantitative meta-analysis was needed to pool effect sizes, compare VR exposure systematically with both passive and active alternatives, and look for moderators - including how dose (number of sessions) affected outcomes.
What the researchers did
Opriş and colleagues conducted a systematic review and quantitative meta-analysis of randomized controlled trials of VR exposure for anxiety disorders. Inclusion criteria required random assignment, a clearly defined VR-based exposure intervention, and standardized anxiety outcome measures. The authors extracted effect sizes for VR exposure versus waitlist or no-treatment controls, versus active evidence-based interventions, and looked at moderators including the number of sessions delivered, the type of anxiety condition, and follow-up duration.
What they found
Pooled effect sizes for VR exposure versus waitlist were large and statistically significant. Comparisons against active evidence-based interventions found no significant differences - VR exposure produced equivalent post-treatment efficacy to non-VR exposure-based approaches. A dose-response relationship was documented: studies that delivered more sessions reported larger effect sizes, indicating that the benefits of VR exposure scale with practice volume in the way exposure-based therapies generally do. Real-life impact and stability of gains over follow-up periods were comparable across VR and non-VR conditions. Dropout rates in VR exposure matched those in in-vivo exposure, indicating no attrition penalty for the modality.
Why this matters
This meta-analysis addressed a practical question that individual trials could not answer alone: does the body of evidence, taken together, support VR exposure as a credible alternative to established anxiety treatments? The pooled answer is yes. The dose-response finding has direct clinical implications - it argues against treating VR as a one-session demonstration and toward planning multi-session practice progressions. For speech-language professionals supporting clients whose speaking work involves anxiety, the meta-analysis offers cross-condition evidence that the broader VR-exposure framework is viable, with the dose-response signal arguing for sustained rather than episodic use.
Limitations
The meta-analysis pooled across heterogeneous primary studies - different anxiety conditions, different VR systems, different dose ranges. Pooled effect sizes from heterogeneous trials must be interpreted as central-tendency estimates rather than precise predictions for any specific scenario. The number of high-quality RCTs available at the time was modest, which constrains the precision of pooled estimates. Direct evidence for communication-specific populations (people who stutter, voice clients) was not captured because primary trials targeted anxiety conditions rather than communication differences.
Implications for practice
Clinicians can offer VR exposure as a credible alternative to established approaches for anxiety, not just as a preparatory step. The dose-response finding supports planning multiple sessions: a single session is unlikely to deliver the available benefit. Lower logistical demand than in-vivo exposure makes longer practice courses feasible.
Implications for research
Larger primary RCTs with active comparators, pre-registration, and pre-specified non-inferiority designs would strengthen the evidence. Subgroup analyzes by specific anxiety condition (social anxiety vs. specific phobia vs. PTSD) would help clinicians and researchers select the right comparison points.
Where this connects to Therapy withVR
The study above is independent research and does not endorse any product. The notes below are commentary from withVR on how the themes in this research relate to features of Therapy withVR. The research findings are not claims about Therapy withVR.
Graded Exposure Hierarchy
This meta-analysis confirmed dose-response across anxiety disorders - Therapy withVR's structured environments support the multi-session practice progressions the analysis identified as necessary.
Save Setup
Save and reload exact configurations across sessions - supporting the consistent, repeatable practice that produced the dose-response effects in this meta-analysis.
Cite this study
If you reference this study in your work, the canonical citation formats are:
@article{opri2012,
author = {Opriş, D. and Pintea, S. and García-Palacios, A. and Botella, C. and Szamosközi Ş and David, D.},
title = {Virtual reality exposure therapy in anxiety disorders: a quantitative meta-analysis},
journal = {Depression and Anxiety},
year = {2012},
doi = {10.1002/da.20910},
url = {https://withvr.app/evidence/studies/opris-2012}
}TY - JOUR
AU - Opriş, D.
AU - Pintea, S.
AU - García-Palacios, A.
AU - Botella, C.
AU - Szamosközi Ş
AU - David, D.
TI - Virtual reality exposure therapy in anxiety disorders: a quantitative meta-analysis
JO - Depression and Anxiety
PY - 2012
DO - 10.1002/da.20910
UR - https://withvr.app/evidence/studies/opris-2012
ER - Know of research that should be in this hub? If a relevant peer-reviewed study is not listed here, send the reference to hello@withvr.app. The hub is kept up to date as the literature grows.
Funding & independence
Funded by Ministerio de Ciencia e Innovación, Spain (contract grant number PSI2010-17563). Authors affiliated with Babes-Bolyai University Cluj-Napoca, Romania (Opriş, Pintea, David, Szamosközi); Jaume I University, Castellón, Spain (García-Palacios, Botella); and Mount Sinai School of Medicine, New York (David). No withVR BV involvement in funding, study design, or authorship. Summary prepared independently by withVR using the published paper.